Y0002055

Fingolimod hydrochloride

European Pharmacopoeia (EP) Reference Standard

• Sinónimos: FTY720, 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol hydrochloride, Fingolimod hydrochloride
• Fórmula empírica (notación de Hill): C₁₉H₃₃NO₂ · HCl
• Número de CAS: 162359-56-0
• Peso molecular: 343.93
• Código UNSPSC: 41116107
• NACRES: NA.24

Propiedades

• origen biológico: synthetic
• grado: pharmaceutical primary standard
• Agency: EP
• familia API: fingolimod
• Formulario: powder
• envase: pkg of 110 mg
• fabricante / nombre comercial: EDQM
• condiciones de almacenamiento: protect from light
• solubilidad: water: 100-1000 g/L
• aplicaciones: pharmaceutical
• Formato: neat
• Condiciones de envío: ambient
• temp. de almacenamiento: 2-8°C
• cadena SMILES: Cl.NC(CO)(CO)CCc1ccc(cc1)CCCCCCCC
• InChI: 1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H
• Clave InChI: SWZTYAVBMYWFGS-UHFFFAOYSA-N

Descripción

Descripción general

Fingolimod Hydrochloride (fingolimod HCl), an S1P-receptor modulator, belongs to the class of synthetic glucocorticoid steroid drugs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicación

This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.

Acciones bioquímicas o fisiológicas

FTY720 is an immunomodulating drug and sphingosine 1-phosphate (S1P) receptor modulator. Phosphorylation of FTY270 by sphingosine kinase causes S1P1R internalization, which sequesters lymphocytes in lymph nodes, preventing them from taking part in an autoimmune response. Clinically, it has been approved for the treatment of multiple sclerosis (MS). It has also been shown to block and reverse paclitaxel-induced chemotherapy induced peripheral neuropathy (CIPN) through S1PR inhibition as well as inhibit the activity of histone deacetylases in the hippocampus of mouse brains, thereby modulating memory.

FTY720, an immunomodulating drug, acts as a sphingosine 1-phosphate (S1P) receptor modulator.

Envase

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Otras notas

Sales restrictions may apply.

Información de seguridad

• Pictogramas: GHS08
• Palabra de señalización: Warning
• Frases de peligro: H373
• Consejos de prudencia: P260 - P314 - P501
• Clasificaciones de peligro: STOT RE 2
• Órganos de actuación: Immune system
• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3
• Punto de inflamabilidad (°F): Not applicable
• Punto de inflamabilidad (°C): Not applicable